He can't as he is limited to one post a day on BMSN board here. There is another place he "hangsout where investors go." Do a google search to find it. He'll answer there. In fact more people should go there.
As for BMSN, Koos really has taken the wind out of this with the delay in getting HemaXellerate approved for clinical trials. It will hurt the pending trading of REGEN, imho.
News 
Market Data 
Discover 
